HORIZON (OP-106): melflufen plus dexamethasone in 55 patients with relapsed/refractory multiple myeloma (RRMM) with extramedullary disease (EMD): subgroup analysis

Autores: Richardson, P. G.; Mateos, M. V.; Oriol, A.; Larocca, A.; Cavo, M. ; Rodríguez Otero, Paula; Leleu, X.; Norkin, M.; Nadeem, O. ; Hiemenz, J. W. ; Hassoun, H.; Touzeau, C. ; Alegre, A. ; Paner, A.; Maisel, C.; Mazumder, A.; Raptis, A. ; Puig, N.; Zamagni, E.; Thuresson, M. ; Harmenberg, J.; Harlin, O.; Blade, J.